Eric D Achtyes, MD, MS

Bluhm R., Sipahi E.D., Achtyes E.D., McCright A.M., Cabrera L.Y. Stakeholders’ Ethical Concerns Regarding Psychiatric Electroceutical Interventions: Results from a US Nationwide Survey AJOB Empirical Bioethics. 2024;15:11-21.

Cunningham J.E., Bluhm R., Achtyes E.D., McCright A.M., Cabrera L.Y. Guideline-based care for psychiatric electroceuticals: Results from a National Survey of Board-Certified Psychiatrists Journal of Evaluation in Clinical Practice. 2024;30:290-295.

Cunningham J.E., Bluhm R., Achtyes E.D., McCright A.M., Cabrera L.Y. The differential effects of psychiatrists' and patients’ prior experiences on views about psychiatric electroceutical interventions Journal of Psychiatric Research. 2024;170:11-18.

Lee-Easton M.J., Magura S., Abu-Obaid R., Reed P., Allgaier B., Fish E., Maletta A., Amaratunga P., Lorenz-Lemberg B., Levitas M., Achtyes E.D. Direct-To-Definitive Urine and Oral Fluid Test Results for Unscreened and Rarely Screened Drugs in Individuals Applying for Methadone Treatment in 7 U.S. States Journal of Psychoactive Drugs. 2024

Monteith S., Glenn T., Geddes J.R., Whybrow P.C., Achtyes E., Bauer M. Artificial intelligence and increasing misinformation British Journal of Psychiatry. 2024;224:33-35.

Monteith S., Glenn T., Geddes J.R., Whybrow P.C., Achtyes E.D., Bauer M. Implications of Online Self-Diagnosis in Psychiatry Pharmacopsychiatry. 2024;57:45-52.

Müller F., Abdelnour A.M., Rutaremara D.N., Arnetz J.E., Achtyes E.D., Alshaarawy O., Holman H.T. Association between sociodemographic factors, clinic characteristics and mental health screening rates in primary care PLoS ONE. 2024;19

Parikh S.V., Vande Voort J.L., Yocum A.K., Achtyes E., Goes F.S., Nykamp L., Singh B., Lopez-Vives D., Sera C.E., Maixner D., Tarnal V., Severe J., Bartek S., Tye S.J., Rico J., Stoppel C.J., Becerra A., Smart L.A., Miller C.R., Frye M.A., Greden J.F., Bobo W.V. Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression Journal of Affective Disorders. 2024;348:143-151.

Singh B., Parikh S.V., Voort J.L.V., Pazdernik V.K., Achtyes E.D., Goes F.S., Yocum A.K., Nykamp L., Becerra A., Smart L.A., Greden J.F., Bobo W.V., Frye M.A., Burdick K.E., Ryan K.A. Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial Psychiatry Research. 2024;335

Achtyes E., Glenn T., Monteith S., Geddes J.R., Bauer M., Whybrow P.C. Technology exceptionalism in medicine: Is it time to rethink the paradigm? European Neuropsychopharmacology. 2023;74:30-31.

Achtyes E.D., Glenn T., Monteith S., Geddes J.R., Whybrow P.C., Martini J., Bauer M. Telepsychiatry in an Era of Digital Mental Health Startups Current Psychiatry Reports. 2023;25:263-272.

Achtyes E.D., Hopkins S.C., Dedic N., Dworak H., Zeni C., Koblan K. Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia European Archives of Psychiatry and Clinical Neuroscience. 2023;273:1543-1556.

Bauer M., Glenn T., Achtyes E.D., Alda M., Agaoglu E., Altınbaş K., Andreassen O.A., Angelopoulos E., Ardau R., Aydin M., Ayhan Y., Baethge C., Bauer R., Baune B.T., Balaban C., Becerra-Palars C., Behere A.P., Behere P.B., Belete H., Belete T., Belizario G.O., Bellivier F., Belmaker R.H., Benedetti F., Berk M., Bersudsky Y., Bicakci Ş., Birabwa-Oketcho H., Bjella T.D., Brady C., Cabrera J., Cappucciati M., Castro A.M.P., Chen W.L., Cheung E.Y.W., Chiesa S., Crowe M., Cuomo A., Dallaspezia S., Del Zompo M., Desai P., Dodd S., Etain B., Fagiolini A., Fellendorf F.T., Ferensztajn-Rochowiak E., Fiedorowicz J.G., Fountoulakis K.N., Frye M.A., Geoffroy P.A., Gitlin M.J., Gonzalez-Pinto A., Gottlieb J.F., Grof P., Haarman B.C.M., Harima H., Hasse-Sousa M., Henry C., Hoffding L., Houenou J., Imbesi M., Isometsä E.T., Ivkovic M., Janno S., Johnsen S., Kapczinski F., Karakatsoulis G.N., Kardell M., Kessing L.V., Kim S.J., König B., Kot T.L., Koval M., Kunz M., Lafer B., Landén M., Larsen E.R., Lenger M., Licht R.W., Lopez-Jaramillo C., MacKenzie A., Madsen H.Ø., Madsen S.A.K.A., Mahadevan J., Mahardika A., Manchia M., Marsh W., Martinez-Cengotitabengoa M., Martini J., Martiny K., Mashima Y., McLoughlin D.M., Meesters Y., Melle I., Meza-Urzúa F., Mikolas P., Mok Y.M., Monteith S., Moorthy M., Morken G. Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder International Journal of Bipolar Disorders. 2023;11

Bluhm R., Cortright M., Achtyes E.D., Cabrera L.Y. “They Are Invasive in Different Ways.”: Stakeholders’ Perceptions of the Invasiveness of Psychiatric Electroceutical Interventions AJOB Neuroscience. 2023;14(1):1-12.

Cabrera L.Y., Achtyes E.D., Bluhm R., McCright A.M. Views about neuromodulation interventions for depression by stakeholder group, treatment modality, and depression severity Comprehensive Psychiatry. 2023;122

Cai Chen S., Bluhm R., Achtyes E.D., McCright A.M., Cabrera L.Y. Looking through the lens of stigma: Understanding and anticipating concerns about the responsible development and use of psychiatric electroceutical interventions (PEIs) SSM - Mental Health. 2023;4

Haider B., O’sullivan A.K., Bessonova L., Keane E., Achtyes E., Harvey P.D., Kane J.M., Saklad S.R., Trotter J.P., Claxton A., Polak T., McGrory J., Noori W., Kessler A.S., Yarlas A., Velligan D. Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic Neuropsychiatric Disease and Treatment. 2023;19:623-634.

Homan P., Schooler N.R., Brunette M.F., Rotondi A., Ben-Zeev D., Gottlieb J.D., Mueser K.T., Achtyes E.D., Gingerich S., Marcy P., Meyer-Kalos P., Hauser M., John M., Robinson D.G., Kane J.M. Relapse prevention through health technology program reduces hospitalization in schizophrenia Psychological Medicine. 2023;53:4114-4120.

Kane J.M., Kishimoto T., Achtyes E., Rubio J., Correll C. The use of long-acting injectables in early-phase schizophrenia The Lancet Psychiatry. 2023;10(7):480-481.

Lapidos A., Lopez-Vives D., Sera C.E., Ahearn E., Vest E., Senic I., Vande Voort J.L., Frye M., Goes F.S., Achtyes E., Greden J., Parikh S.V. Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression Journal of Affective Disorders. 2023;323:534-539.

Magura S., Lee-Easton M.J., Abu-Obaid R., Reed P., Allgaier B., Amaratunga P., Lorenz-Lemberg B., Levitas M., Achtyes E.D. Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs Drug and Alcohol Dependence. 2023;250

Magura S., Lee-Easton M.J., Abu-Obaid R., Reed P., Allgaier B., Fish E., Maletta A.L., Amaratunga P., Lorenz-Lemberg B., Levitas M., Achtyes E.D. Prevalence and drug use correlates of inadvertent fentanyl exposure among individuals misusing drugs in seven U.S. states Journal of Addictive Diseases. 2023

Monteith S., Glenn T., Geddes J.R., Achtyes E.D., Whybrow P.C., Bauer M. Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: A Narrative Review Pharmacopsychiatry. 2023;56:209-213.

Müller F., Abdelnour A.M., Rutaremara D.N., Arnetz J.E., Achtyes E.D., Alshaarawy O., Holman H.T. Mental Health Screening Differences in Non-English Speaking Patients: Results From a Retrospective Cohort Study Journal of Primary Care and Community Health. 2023;14

Müller F., Munagala A., Arnetz J.E., Achtyes E.D., Alshaarawy O., Holman H.T. Racial disparities in emergency department utilization among patients with newly diagnosed depression General Hospital Psychiatry. 2023;85:163-170.

Sha Q., Fu Z., Escobar Galvis M.L., Madaj Z., Underwood M.D., Steiner J.A., Dwork A., Simpson N., Galfalvy H., Rozoklija G., Achtyes E.D., Mann J.J., Brundin L. Integrative transcriptome- and DNA methylation analysis of brain tissue from the temporal pole in suicide decedents and their controls Molecular Psychiatry. 2023

Aikens J.E., Valenstein M., Plegue M.A., Sen A., Marinec N., Achtyes E., Piette J.D. Technology-Facilitated Depression Self-Management Linked with Lay Supporters and Primary Care Clinics: Randomized Controlled Trial in a Low-Income Sample Telemedicine and e-Health. 2022;28(3):399-406.

Bauer M., Glenn T., Achtyes E.D., Alda M., Agaoglu E., Altınbaş K., Andreassen O.A., Angelopoulos E., Ardau R., Aydin M., Ayhan Y., Baethge C., Bauer R., Baune B.T., Balaban C., Becerra-Palars C., Behere A.P., Behere P.B., Belete H., Belete T., Belizario G.O., Bellivier F., Belmaker R.H., Benedetti F., Berk M., Bersudsky Y., Bicakci Ş., Birabwa-Oketcho H., Bjella T.D., Brady C., Cabrera J., Cappucciati M., Castro A.M.P., Chen W.L., Cheung E.Y.W., Chiesa S., Crowe M., Cuomo A., Dallaspezia S., Del Zompo M., Desai P., Dodd S., Etain B., Fagiolini A., Fellendorf F.T., Ferensztajn-Rochowiak E., Fiedorowicz J.G., Fountoulakis K.N., Frye M.A., Geoffroy P.A., Gonzalez-Pinto A., Gottlieb J.F., Grof P., Haarman B.C.M., Harima H., Hasse-Sousa M., Henry C., Høffding L., Houenou J., Imbesi M., Isometsä E.T., Ivkovic M., Janno S., Johnsen S., Kapczinski F., Karakatsoulis G.N., Kardell M., Kessing L.V., Kim S.J., König B., Kot T.L., Koval M., Kunz M., Lafer B., Landén M., Larsen E.R., Lenger M., Lewitzka U., Licht R.W., Lopez-Jaramillo C., MacKenzie A., Madsen H.Ø., Madsen S.A.K.A., Mahadevan J., Mahardika A., Manchia M., Marsh W., Martinez-Cengotitabengoa M., Martiny K., Mashima Y., McLoughlin D.M., Meesters Y., Melle I., Meza-Urzúa F., Mok Y.M., Monteith S., Moorthy M., Morken G., Mosca E., Mozzhegorov A.A. Association between polarity of first episode and solar insolation in bipolar I disorder Journal of Psychosomatic Research. 2022;160

Cabrera L.Y., Gilbert M.M.C., Achtyes E.D., McCright A.M., Bluhm R. Jumping through the hoops: Barriers and other ethical concerns regarding the use of psychiatric electroceutical interventions Psychiatry Research. 2022;313

Fattal J., Brascamp J.W., Slate R.E., Lehet M., Achtyes E.D., Thakkar K.N. Blunted pupil light reflex is associated with negative symptoms and working memory in individuals with schizophrenia Schizophrenia Research. 2022;248:254-262.

Hardt K., Vandebosch A., Sadoff J., Le Gars M., Truyers C., Lowson D., Van Dromme I., Vingerhoets J., Kamphuis T., Scheper G., Ruiz-Guiñazú J., Faust S.N., Spinner C.D., Schuitemaker H., Van Hoof J., Douoguih M., Struyf F., Garibaldi B.T., Albertson T.E., Sandrock C., Lee J.S., Looney M.R., Tapson V.F., Wiysonge C.S., Velarde L.H.A., Backenroth D., Bhushanan J., Brandenburg B., Cárdenas V., Chen B., Chen F., Chetty P., Chu P.L., Cooper K., Custers J., Delanghe H., Duca A., Henrick T., Juraszek J., Nalpas C., Peeters M., Pinheiro J., Roels S., Ryser M.F., Salas J., Santoro Matias S., Scheys I., Shetty P., Shukarev G., Stoddard J., Talloen W., Tran N.P., Vaissiere N., van Son-Palmen E., Xu J., Goecker E.A., Greninger A.L., Jerome K.R., Roychoudhury P., Takuva S.G., Accini Mendoza J.L., Achtyes E., Ahsan H., Alhatemi A., Allen N., Arribas J.R., Bahrami G., Bailon L., Bajwa A., Baker J., Baron M., Benet S., Berdaï D., Berger P., Bertoch T., Bethune C., Bevilacqua S., Biagioni Santos M.S., Binnian I., Bisnauthsing K., Boivin J.M., Bollen H., Bonnet S., Borobia A.M., Botelho-Nevers E., Bright P., Britten V., Brown C., Buadi A., Buntinx E., Burgess L., Bush L., Capeding M.R., Carr Q.O., Carrasco Mas A., Catala H., Cathie K., Caudill T.S., Cereto Castro F., Chau K. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet Infectious Diseases. 2022;22(12):1703-1715.

Medeiros G.C., Gould T.D., Prueitt W.L., Nanavati J., Grunebaum M.F., Farber N.B., Singh B., Selvaraj S., Machado-Vieira R., Achtyes E.D., Parikh S.V., Frye M.A., Zarate C.A., Goes F.S. Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis Molecular Psychiatry. 2022;27(9):3658-3669.

Monteith S., Glenn T., Geddes J., Whybrow P.C., Achtyes E., Bauer M. Expectations for Artificial Intelligence (AI) in Psychiatry Current Psychiatry Reports. 2022;24(11):709-721.

Mueser K.T., Achtyes E.D., Gogate J., Mancevski B., Kim E., Starr H.L. Telehealth-Based Psychoeducation for Caregivers: The Family Intervention in Recent-Onset Schizophrenia Treatment Study JMIR Mental Health. 2022;9(4)

Sha Q., Madaj Z., Keaton S., Escobar Galvis M.L., Smart L.A., Krzyzanowski S., Fazleabas A.T., Leach R., Postolache T.T., Achtyes E.D., Brundin L. Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy Translational Psychiatry. 2022;12(1)

Stilwell K., Pelkey L., Platt T., Nguyen K., Monteith S., Pinheiro A., Achtyes E.D. Survey of Primary Care Provider Comfort in Treating Psychiatric Patients in 2 Community Clinics: A Pilot Study Primary Care Companion for CNS Disorders. 2022;24(1)

Zandi P.P., Morreale M., Reti I.M., Maixner D.F., McDonald W.M., Patel P.D., Achtyes E., Bhati M.T., Carr B.R., Conroy S.K., Cristancho M., Dubin M.J., Francis A., Glazer K., Ingram W., Khurshid K., McClintock S.M., Pinjari O.F., Reeves K., Rodriguez N.F., Sampson S., Seiner S.J., Selek S., Sheline Y., Smetana R.W., Soda T., Trapp N.T., Wright J.H., Husain M., Weiner R.D. National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive Therapy Journal of ECT. 2022;38(3):159-164.

Achtyes E.D., Gega L., Linnaranta O. Editorial: mHealth: Self-Management and Complementary Psychiatric Treatment Frontiers in Psychiatry. 2021;12

Bauer M., Glenn T., Achtyes E.D., Alda M., Agaoglu E., Altınbaş K., Andreassen O.A., Angelopoulos E., Ardau R., Vares E.A., Aydin M., Ayhan Y., Baethge C., Bauer R., Baune B.T., Balaban C., Becerra-Palars C., Behere A.P., Behere P.B., Belete H., Belete T., Belizario G.O., Bellivier F., Belmaker R.H., Benedetti F., Berk M., Bersudsky Y., Bicakci Ş., Birabwa-Oketcho H., Bjella T.D., Brady C., Cabrera J., Cappucciati M., Castro A.M.P., Chen W.L., Cheung E.Y.W., Chiesa S., Crowe M., Cuomo A., Dallaspezia S., Del Zompo M., Desai P., Dodd S., Donix M., Etain B., Fagiolini A., Fellendorf F.T., Ferensztajn-Rochowiak E., Fiedorowicz J.G., Fountoulakis K.N., Frye M.A., Geoffroy P.A., Gonzalez-Pinto A., Gottlieb J.F., Grof P., Haarman B.C.M., Harima H., Hasse-Sousa M., Henry C., Høffding L., Houenou J., Imbesi M., Isometsä E.T., Ivkovic M., Janno S., Johnsen S., Kapczinski F., Karakatsoulis G.N., Kardell M., Kessing L.V., Kim S.J., König B., Kot T.L., Koval M., Kunz M., Lafer B., Landén M., Larsen E.R., Lenger M., Lewitzka U., Licht R.W., Lopez-Jaramillo C., MacKenzie A., Madsen H.Ø., Madsen S.A.K.A., Mahadevan J., Mahardika A., Manchia M., Marsh W., Martinez-Cengotitabengoa M., Martiny K., Mashima Y., McLoughlin D.M., Meesters Y., Melle I., Meza-Urzúa F., Ming M.Y., Monteith S., Moorthy M., Morken G. Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder International Journal of Bipolar Disorders. 2021;9(1)

Bigdeli T.B., Fanous A.H., Li Y., Rajeevan N., Sayward F., Genovese G., Gupta R., Radhakrishnan K., Malhotra A.K., Sun N., Lu Q., Hu Y., Li B., Chen Q., Mane S., Miller P., Cheung K.H., Gur R.E., Greenwood T.A., Braff D.L., Achtyes E.D., Buckley P.F., Escamilla M.A., Lehrer D., Malaspina D.P., McCarroll S.A., Rapaport M.H., Vawter M.P., Pato M.T., Pato C.N., Zhao H., Kosten T.R., Brophy M., Pyarajan S., Shi Y., O'Leary T.J., Gleason T., Przygodzki R., Muralidhar S., Gaziano J.M., Huang G.D., Concato J., Siever L.J., Aslan M., Harvey P.D. Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans Schizophrenia Bulletin. 2021;47(2):517-529.

Bluhm R., Castillo E., Achtyes E.D., McCright A.M., Cabrera L.Y. They Affect the Person, but for Better or Worse? Perceptions of Electroceutical Interventions for Depression Among Psychiatrists, Patients, and the Public Qualitative Health Research. 2021;31(13):2542-2553.

Brundin L., Achtyes E., Guillemin G.J. Regarding letter on “Kynurenine pathway dysregulation in postpartum depression”, by Achtyes et al, 2020 Brain, Behavior, and Immunity. 2021;91:794-795.

Cabrera L.Y., Gilbert M.M.C., McCright A.M., Achtyes E.D., Bluhm R. Beyond the Cuckoo’s Nest: Patient and Public Attitudes about Psychiatric Electroceutical Interventions Psychiatric Quarterly. 2021;92(4):1425-1438.

Cabrera L.Y., Nowak G.R., McCright A.M., Achtyes E., Bluhm R. A qualitative study of key stakeholders’ perceived risks and benefits of psychiatric electroceutical interventions Health, Risk and Society. 2021;23(5-6):217-235.

Cabrera L.Y., Nowak G.R., McCright A.M., Achtyes E., Bluhm R. Last Resort Interventions?: A Qualitative Study of Psychiatrists’ Experience with and Views on Psychiatric Electroceutical Interventions Psychiatric Quarterly. 2021;92(2):419-430.

Dziadosz G., Spykerman K., Ryskamp B., Achtyes E.D. Total Cost of Therapy-Based Care Versus a Brokerage Model of Case Management for Persons With a Serious Mental Illness Served in the Community Journal of Behavioral Health Services and Research. 2021;48(2):330-341.

Keaton S.A., Arnetz J., Jamil H., Dhalimi A., Stemmer P.M., Ruden D.M., Yamin J., Achtyes E., Smart L.A., Brundin L., Arnetz B.B. IL-10: A possible immunobiological component of positive mental health in refugees Comprehensive Psychoneuroendocrinology. 2021;8

Koko M., Krause R., Sander T., Bobbili D.R., Nothnagel M., May P., Lerche H., Feng Y.C.A., Howrigan D.P., Abbott L.E., Tashman K., Cerrato F., Singh T., Heyne H., Byrnes A.E., Churchhouse C., Watts N., Solomonson M., Lal D., Gupta N., Gabriel S.B., Daly M.J., Lander E.S., Neale B.M., Berkovic S.F., Goldstein D.B., Lowenstein D.H., Cavalleri G.L., Cossette P., Cotsapas C., De Jonghe P., Dixon-Salazar T., Guerrini R., Hakonarson H., Heinzen E.L., Dhindsa R.S., Stanley K.E., Helbig I., Kwan P., Marson A.G., Petrovski S., Kamalakaran S., Sisodiya S.M., Stewart R., Weckhuysen S., Depondt C., Dlugos D.J., Scheffer I.E., Striano P., Freyer C., McKenna K., Regan B.M., Bellows S.T., Leu C., Bennett C.A., Johns E.M.C., MacDonald A., Shilling H., Burgess R., Weckhuysen D., Bahlo M., O'Brien T.J., Todaro M., Stamberger H., Andrade D.M., Sadoway T.R., Mo K., Krestel H., Gallati S., Papacostas S.S., Kousiappa I., Tanteles G.A., Štěrbová K., Vlčková M., Sedláčková L., Laššuthová P., Klein K.M., Rosenow F., Reif P.S., Knake S., Kunz W.S., Zsurka G., Elger C.E., Bauer J., Rademacher M., Pendziwiat M., Muhle H., Rademacher A., Van Baalen A., Von Spiczak S., Stephani U., Afawi Z., Korczyn A.D., Kanaan M., Canavati C., Kurlemann G., Müller-Schlüter K., Kluger G., Häusler M., Blatt I. Distinct gene-set burden patterns underlie common generalized and focal epilepsies eBioMedicine. 2021;72

Landi I., Kaji D.A., Cotter L., Van Vleck T., Belbin G., Preuss M., Loos R.J.F., Kenny E., Glicksberg B.S., Beckmann N.D., O’Reilly P., Schadt E.E., Achtyes E.D., Buckley P.F., Lehrer D., Malaspina D.P., McCarroll S.A., Rapaport M.H., Fanous A.H., Pato M.T., Pato C.N., Bigdeli T.B., Nadkarni G.N., Charney A.W. Prognostic value of polygenic risk scores for adults with psychosis Nature Medicine. 2021;27(9):1576-1581.

Parikh S.V., Lopez D., Vande Voort J.L., Rico J., Achtyes E., Coryell W., Goddard A., Goes F., Greden J.F., Singh B., Kaplin A., Frye M.A., Maixner D., Watson B., Drake K., Tarnal V., Riva-Posse P., Bobo W.V., Bio-K Study Team Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer Psychopharmacology bulletin. 2021;51(3):109-124.

Sha Q., Achtyes E., Nagalla M., Keaton S., Smart L.A., Leach R., Brundin L. Associations between estrogen and progesterone, the kynurenine pathway, and inflammation in the post-partum Journal of Affective Disorders. 2021;281:9-12.

Thakkar K.N., Ghermezi L., Silverstein S.M., Slate R., Yao B., Achtyes E.D., Brascamp J.W. Stronger tilt aftereffects in persons with schizophrenia Journal of abnormal psychology. 2021;130(2):186-197.

Voytenko V.L., VanOrman B.T., Jaarsma R.D., Bishop T.W., Mavis B.E., Achtyes E.D. Getting involved in training the next generation of physicians: Examples of practicing psychologists in psychiatry and family medicine residency programs. Professional Psychology: Research and Practice. 2021;52(3):290-298.

Achtyes E., Keaton S.A., Smart L.A., Burmeister A.R., Heilman P.L., Krzyzanowski S., Nagalla M., Guillemin G.J., Escobar Galvis M.L., Lim C.K., Muzik M., Postolache T.T., Leach R., Brundin L. Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression Brain, Behavior, and Immunity. 2020;83:239-247.

Bigdeli T.B., Genovese G., Georgakopoulos P., Meyers J.L., Peterson R.E., Iyegbe C.O., Medeiros H., Valderrama J., Achtyes E.D., Kotov R., Stahl E.A., Abbott C., Azevedo M.H., Belliveau R.A., Bevilacqua E., Bromet E.J., Byerley W., Carvalho C.B., Chapman S.B., DeLisi L.E., Dumont A.L., O’Dushlaine C., Evgrafov O.V., Fochtmann L.J., Gage D., Kennedy J.L., Kinkead B., Macedo A., Moran J.L., Morley C.P., Dewan M.J., Nemesh J., Perkins D.O., Purcell S.M., Rakofsky J.J., Scolnick E.M., Sklar B.M., Sklar P., Smoller J.W., Sullivan P.F., Macciardi F., Marder S.R., Gur R.C., Gur R.E., Braff D.L., Calkins M.E., Freedman R.R., Green M.F., Greenwood T.A., Lazzeroni L.C., Light G.A., Nuechterlein K.H., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Sugar C.A., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Nicolini H., Escamilla M.A., Vawter M.P., Sobell J.L., Malaspina D., Lehrer D.S., Buckley P.F., Rapaport M.H., Knowles J.A., Fanous A.H., Pato M.T., McCarroll S.A., Pato C.N. Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry Molecular Psychiatry. 2020;25(10):2455-2467.

Kane J.M., Schooler N.R., Marcy P., Correll C.U., Achtyes E.D., Gibbons R.D., Robinson D.G. Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial JAMA Psychiatry. 2020;77(12):1217-1224.

Kopec K., Janney C.A., Johnson B., Spykerman K., Ryskamp B., Achtyes E.D. Rapid Transition to Telehealth in a Community Mental Health Service Provider During the COVID-19 Pandemic Primary Care Companion for CNS Disorders. 2020;22(5)

Soda T., McLoughlin D.M., Clark S.R., Oltedal L., Kessler U., Haavik J., Bousman C., Smith D.J., Bioque M., Clements C.C., Loo C., Vila-Rodriguez F., Minelli A., Mickey B.J., Milev R., Docherty A.R., Langan Martin J., Achtyes E.D., Arolt V., Redlich R., Dannlowski U., Cardoner N., Clare E., Craddock N., Di Florio A., Dmitrzak-Weglarz M., Forty L., Gordon-Smith K., Husain M., Ingram W.M., Jones L., Jones I., Juruena M., Kirov G., Landén M., Müller D.J., Nordensköld A., Pålsson E., Paul M., Permoda A., Pliszka B., Rea J., Schubert K.O., Sonnen J.A., Soria V., Stageman W., Takamiya A., Urretavizacaya M., Watson S., Zavorotny M., Young A.H., Vieta E., Rybakowski J.K., Gennarelli M., Zandi P.P., Sullivan P.F., Baune B.T. International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic) European Archives of Psychiatry and Clinical Neuroscience. 2020;270(7):921-932.

Achtyes E.D., Ben-Zeev D., Luo Z., Mayle H., Burke B., Rotondi A.J., Gottlieb J.D., Brunette M.F., Mueser K.T., Gingerich S., Meyer-Kalos P.S., Marcy P., Schooler N.R., Robinson D.G., Kane J.M. Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospital Schizophrenia Research. 2019;206:200-208.

Brundin L., Achtyes E. Has the time come to treat depression with anti-inflammatory medication? Acta Psychiatrica Scandinavica. 2019;139(5):401-403.

Brunette M.F., Achtyes E., Pratt S., Stilwell K., Opperman M., Guarino S., Kay-Lambkin F. Use of Smartphones, Computers and Social Media Among People with SMI: Opportunity for Intervention Community Mental Health Journal. 2019;55(6):973-978.

Feng Y.C.A., Howrigan D.P., Abbott L.E., Tashman K., Cerrato F., Singh T., Heyne H., Byrnes A., Churchhouse C., Watts N., Solomonson M., Lal D., Heinzen E.L., Dhindsa R.S., Stanley K.E., Cavalleri G.L., Hakonarson H., Helbig I., Krause R., May P., Weckhuysen S., Petrovski S., Kamalakaran S., Sisodiya S.M., Cossette P., Cotsapas C., De Jonghe P., Dixon-Salazar T., Guerrini R., Kwan P., Marson A.G., Stewart R., Depondt C., Dlugos D.J., Scheffer I.E., Striano P., Freyer C., McKenna K., Regan B.M., Bellows S.T., Leu C., Bennett C.A., Johns E.M.C., Macdonald A., Shilling H., Burgess R., Weckhuysen D., Bahlo M., O'Brien T.J., Todaro M., Stamberger H., Andrade D.M., Sadoway T.R., Mo K., Krestel H., Gallati S., Papacostas S.S., Kousiappa I., Tanteles G.A., Štěrbová K., Vlčková M., Sedláčková L., Laššuthová P., Klein K.M., Rosenow F., Reif P.S., Knake S., Kunz W.S., Zsurka G., Elger C.E., Bauer J., Rademacher M., Pendziwiat M., Muhle H., Rademacher A., van Baalen A., von Spiczak S., Stephani U., Afawi Z., Korczyn A.D., Kanaan M., Canavati C., Kurlemann G., Müller-Schlüter K., Kluger G., Häusler M., Blatt I., Lemke J.R., Krey I., Weber Y.G., Wolking S., Becker F., Hengsbach C., Rau S., Maisch A.F., Steinhoff B.J., Schulze-Bonhage A., Schubert-Bast S., Schreiber H., Borggräfe I. Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals American Journal of Human Genetics. 2019;105(2):267-282.

Kane J.M., Schooler N.R., Marcy P., Achtyes E.D., Correll C.U., Robinson D.G. Patients with early-phase schizophrenia will accept treatment with sustained-release medication (long-acting injectable antipsychotics): Results from the recruitment phase of the PRELAPSE trial Journal of Clinical Psychiatry. 2019;80(3)

Keaton S.A., Madaj Z.B., Heilman P., Smart L.A., Grit J., Gibbons R., Postolache T.T., Roaten K., Achtyes E.D., Brundin L. An inflammatory profile linked to increased suicide risk Journal of Affective Disorders. 2019;247:57-65.

Nuttall A.K., Thakkar K.N., Luo X., Mueser K.T., Glynn S.M., Achtyes E.D., Kane J.M. Longitudinal associations of family burden and patient quality of life in the context of first-episode schizophrenia in the RAISE-ETP study Psychiatry Research. 2019;276:60-68.

Achtyes E., Simmons A., Skabeev A., Levy N., Jiang Y., Marcy P., Weiden P.J. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: A survey of patients living with schizophrenia BMC Psychiatry. 2018;18(1)

Voytenko V., Anderson K., Wyngarden N., Post D., Achtyes E., Thomas S., Edwards E., Stoyanov R., Nykamp L., Lee S.H. Evidence-based practice guideline for the treatment of adult patients with depressive disorders. Part II: Psychotherapy Psychiatria i Psychologia Kliniczna. 2018;18(3):242-247.

Voytenko V., Nykamp L., Achtyes E., Stoyanov R., Anderson K., Thomas S., Lee S.H., Edwards E., Post D., Wyngarden N. Evidence-based practice guideline for the treatment of adult patients with depressive disorders. Part I: Psychiatric management Psychiatria i Psychologia Kliniczna. 2018;18(3):234-241.

Bryleva E.Y., Keaton S.A., Grit J., Madaj Z., Sauro-Nagendra A., Smart L., Halstead S., Achtyes E., Brundin L. The acute-phase mediator serum amyloid A is associated with symptoms of depression and fatigue Acta Psychiatrica Scandinavica. 2017;135(5):409-418.

Cather C., Hoeppner S., Pachas G., Pratt S., Achtyes E., Cieslak K.M., Evins A.E. Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy Journal of Dual Diagnosis. 2017;13(3):168-178.

Baumel A., Correll C.U., Hauser M., Brunette M., Rotondi A., Ben-Zeev D., Gottlieb J.D., Mueser K.T., Achtyes E.D., Schooler N.R., Robinson D.G., Gingerich S., Marcy P., Meyer-Kalos P., Kane J.M. Health technology intervention after hospitalization for schizophrenia: Service utilization and user satisfaction Psychiatric Services. 2016;67(9):1035-1038.

Ben-Zeev D., Scherer E.A., Gottlieb J.D., Rotondi A.J., Brunette M.F., Achtyes E.D., Mueser K.T., Gingerich S., Brenner C.J., Begale M., Mohr D.C., Schooler N., Marcy P., Robinson D.G., Kane J.M. MHealth for schizophrenia: Patient engagement with a mobile phone intervention following hospital discharge JMIR Mental Health. 2016;3(3)

Brunette M.F., Rotondi A.J., Ben-Zeev D., Gottlieb J.D., Mueser K.T., Robinson D.G., Achtyes E.D., Gingerich S., Marcy P., Schooler N.R., Meyer-Kalos P., Kane J.M. Coordinated technology-delivered treatment to prevent rehospitalization in schizophrenia: A novel model of care Psychiatric Services. 2016;67(4):444-447.

Thorndike A.N., Achtyes E.D., Cather C., Pratt S., Pachas G.N., Hoeppner S.S., Eden Evins A. Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: A subgroup analysis of a randomized trial Journal of Clinical Psychiatry. 2016;77(3):e320-e326.

Acharya D., Harper D.G., Achtyes E.D., Seiner S.J., Mahdasian J.A., Nykamp L.J., Adkison L., Van White L.D.S., McClintock S.M., Ujkaj M., Davidoff D.A., Forester B.P. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia International Journal of Geriatric Psychiatry. 2015;30(3):265-273.

Achtyes E.D., Halstead S., Smart L.A., Moore T., Frank E., Kupfer D.J., Gibbons R. Validation of computerized adaptive testing in an outpatient nonacademic setting: The VOCATIONS trial Psychiatric Services. 2015;66(10):1091-1096.

Brundin L., Erhardt S., Bryleva E.Y., Achtyes E.D., Postolache T.T. The role of inflammation in suicidal behaviour Acta Psychiatrica Scandinavica. 2015;132(3):192-203.

Magura S., Achtyes E.D., Batts K., Platt T., Moore T.L. Adding urine and saliva toxicology to SBIRT for drug screening of new patients American Journal on Addictions. 2015;24(5):396-399.

Evins A.E., Cather C., Pratt S.A., Pachas G.N., Hoeppner S.S., Goff D.C., Achtyes E.D., Ayer D., Schoenfeld D.A. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial JAMA. 2014;311(2):145-154.

Goff D.C., McEvoy J.P., Citrome L., Mech A.W., Bustillo J.R., Gil R., Buckley P., Manschreck T.C., Achtyes E.D., Macklin E.A. High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: The ZEBRAS study Journal of Clinical Psychopharmacology. 2013;33(4):485-490.

Palmsten K., Hernández-Díaz S., Huybrechts K.F., Williams P.L., Michels K.B., Achtyes E.D., Mogun H., Setoguchi S. Use of antidepressants near delivery and risk of postpartum hemorrhage: Cohort study of low income women in the United States BMJ (Online). 2013;347(7922)

Roffman J.L., Lamberti J.S., Achtyes E., Macklin E.A., Galendez G.C., Raeke L.H., Silverstein N.J., Smoller J.W., Hill M., Goff D.C. Randomized multicenter investigation of folate plus vitamin B<inf>12</inf> supplementation in schizophrenia JAMA Psychiatry. 2013;70(5):481-489.

Pachas G.N., Cather C., Pratt S.I., Hoeppner B., Nino J., Carlini S.V., Achtyes E.D., Lando H., Mueser K.T., Rigotti N.A., Goff D.C., Evins A.E. Varenicline for smoking cessation in schizophrenia: Safety and effectiveness in a 12-week open-label trial Journal of Dual Diagnosis. 2012;8(2):117-125.

Nakamoto Y., Eisbruch A., Achtyes E.D., Sugawara Y., Reynolds K.R., Johnston C.M., Wahl R.L. Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy Gynecologic Oncology. 2002;84(2):289-295.